Verified Clinical Trials (VCT), the world’s largest global research subject database designed to prevent dual enrollment in clinical trials with duplicate research subjects and protocol violations in clinical trials, proudly announces it has achieved ISO/IEC 27001 certification, the international gold standard for information security management systems (ISMS).
This significant milestone reflects VCT’s ongoing dedication to the highest levels of data privacy, security, and operational excellence across its global platform, which supports pharmaceutical companies, clinical research organizations (CROs), and investigative sites.
“ISO 27001 certification is a landmark achievement for VCT,” said Kerri Weingard, Co-Founder, VP and Global COO. “Our clients trust us with highly sensitive and regulated data. This certification reaffirms that we operate with the most stringent controls to protect that data and the integrity of the research process itself.”
VCT plays a critical role in ensuring research subject compliance by preventing fraudulent and duplicate enrollment in clinical trials, thereby safeguarding protocol fidelity and participant safety. The company’s proprietary technology and global centralized research subject registry is used by countless sponsors of clinical trials and in tens of thousands of research sites globally, across all phases of clinical research and therapeutic areas.
“Achieving ISO 27001 status validates the robustness of our internal systems and processes,” said Palani Masilamani, CTO of Verified Clinical Trials. “It demonstrates that information security is embedded into the DNA of our technology and operations. This is a win not only for VCT but for every sponsor and site that depends on our platform.”
The rigorous ISO/IEC 27001 certification process, conducted by an accredited third-party auditor, required VCT to demonstrate an ongoing and systematic approach to managing sensitive company and customer information. The standard outlines best practices in information security risk management, access control, incident response, and data protection policies.
“This accomplishment reflects our team’s tireless efforts and unwavering commitment to excellence,” added Mitchell Efros, Co-Founder and CEO of Verified Clinical Trials. “ISO certification enhances the trust we’ve built with clients and partners around the world and positions us for continued innovation and leadership in clinical trial compliance.”
With ISO 27001 certification in place, VCT continues to lead the way in promoting integrity and safety in clinical trials, while meeting the evolving regulatory and cybersecurity expectations of the life sciences industry.
Verified Clinical Trials continues to lead the industry with the only global cross-sponsor, cross-therapeutic solution that both detects and prevents protocol violations in real-time at the time of screening. Now backed by ISO certification, VCT offers an even stronger foundation for research integrity and stakeholder trust across the globe.
About Verified Clinical Trials
Verified Clinical Trials (VCT) is the largest and most comprehensive global research subject database to prevent dual enrollment in clinical trials and protocol deviations in clinical trials. Used by leading pharmaceutical companies, CROs, and research sites worldwide, VCT is a trusted partner in improving subject safety, data quality, and regulatory compliance.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250421104300/en/